Emerging trends in focus at eMarketing conference

Share this article:
The ongoing shift towards patient education, the emergence of new technologies and what it all means for electronic pharma marketers was in the spotlight during The Center for Business Intelligence’s 5th Annual eMarketing for the Pharmaceutical Industry conference held in Philadelphia on Monday and Tuesday. Keynote speaker Lori Reilly, PhRMA VP of policy and research, re-emphasized the industry trade group’s commitment to improving the value of consumer pharmaceutical advertising through efforts including is DTC guidelines. “DTC advertising or eMarketing is a big part of that,” Reilly said. “The industry is committed to making improvements to the way we communicate. As more dollars are being transferred from DTC to eMarketing, (people are asking) is this the next area that we need to get involved in? That may be the case in the future.” Industry experts discussed ways to maximize emerging sector trends, such as data collection, and the leveraging of user-generated content. “User-generated content represents the evolution,” Jean-Paul Hepp, director of privacy for Pfizer said. Doug Levy president of IMC2 explained the ways bloggers may be recruited to aid pharma companies in their marketing efforts. Other featured speakers included: *Daniel Murphy, senior e-promotions manager, oncology at AstraZeneca who reviewed the success behind AstraZeneca’s www.getbcfacts.com. *Diana Caldwell, manager e-marketing, Eli Lilly, who discussed elements of the unbranded Web site www.depressionhurts.com. *Don Hackett, general manager and publisher, Revolution Healthcare Group. Hackett discussed some of the ways that technology is changing the ways consumers communicate with healthcare professionals. *Erika Fishman of Manhattan Research, who delivered a presentation on which e-Marketing tactics can be used to seize growth opportunities presented by the multicultural boom.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.